Combination drug therapy for childhood brain tumors shows promise in laboratory models
Monday, February 17, 2020 - 13:20
in Health & Medicine
In experiments with human cells and mice, researchers report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.